Two Sigma Securities, LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $4.77 Million - $5.86 Million	-20,400 Reduced 85.71%	3,400 $935,000
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $2.58 Million - $4.45 Million	18,000 Added 310.34%	23,800 $5.78 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $1.23 Million - $1.66 Million	-8,400 Reduced 59.15%	5,800 $866,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $1.68 Million - $2.18 Million	11,100 Added 358.06%	14,200 $2.72 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $529,387 - $656,115	3,100 New	3,100 $549,000
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $254,360 - $347,820	2,000 New	2,000 $327,000
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $489,786 - $735,268	-4,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $83,808 - $120,591	900 Added 23.68%	4,700 $512,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $104,314 - $173,922	1,400 Added 58.33%	3,800 $438,000
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $953,748 - $1.16 Million	-10,800 Reduced 81.82%	2,400 $236,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $1.53 Million - $1.96 Million	13,200 New	13,200 $1.57 Million

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.